SAM
ALXN

Securian Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Securian Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-19,063
Closed -$3.5M – 999
2021
Q2 		$3.5M Sell
19,063
-100
-0.5% -$17.2K 0.07% 255
2021
Q1 		$2.93M Sell
19,163
-556
-3% -$86K 0.06% 295
2020
Q4 		$3.08M Sell
19,719
-440
-2% -$56.5K 0.07% 266
2020
Q3 		$2.31M Sell
20,159
-424
-2% -$45.7K 0.06% 317
2020
Q2 		$2.31M Sell
20,583
-1,242
-6% -$132K 0.06% 293
2020
Q1 		$1.96M Sell
21,825
-420
-2% -$41.2K 0.06% 299
2019
Q4 		$2.41M Sell
22,245
-1,047
-4% -$112K 0.05% 328
2019
Q3 		$2.28M Sell
23,292
-300
-1% -$33.8K 0.05% 335
2019
Q2 		$3.09M Buy
23,592
+194
+0.8% +$25K 0.07% 267
2019
Q1 		$3.16M Buy
23,398
+267
+1% +$33.2K 0.08% 257
2018
Q4 		$2.25M Buy
23,131
+441
+2% +$52.1K 0.06% 288
2018
Q3 		$3.15M Buy
22,690
+37
+0.2% +$4.64K 0.07% 255
2018
Q2 		$2.81M Buy
22,653
+100
+0.4% +$11.7K 0.07% 271
2018
Q1 		$2.51M Sell
22,553
-200
-0.9% -$23.9K 0.06% 290
2017
Q4 		$2.72M Sell
22,753
-21
-0.1% -$2.56K 0.07% 282
2017
Q3 		$3.19M Buy
22,774
+152
+0.7% +$20.7K 0.08% 245
2017
Q2 		$2.75M Buy
22,622
+4
+0% +$466 0.07% 267
2017
Q1 		$2.74M Buy
22,618
+10
+0% +$1.29K 0.07% 258
2016
Q4 		$2.77M Buy
22,608
+147
+0.7% +$18K 0.07% 260
2016
Q3 		$2.75M Buy
22,461
+226
+1% +$29.1K 0.07% 252
2016
Q2 		$2.6M Buy
22,235
+106
+0.5% +$15K 0.07% 254
2016
Q1 		$3.08M Buy
22,129
+247
+1% +$36.3K 0.09% 225
2015
Q4 		$4.17M Buy
21,882
+583
+3% +$102K 0.12% 172
2015
Q3 		$3.33M Buy
21,299
+76
+0.4% +$13.9K 0.11% 189
2015
Q2 		$3.84M Buy
21,223
+2,362
+13% +$408K 0.12% 180
2015
Q1 		$3.27M Buy
18,861
+843
+5% +$153K 0.1% 212
2014
Q4 		$3.33M Buy
18,018
+481
+3% +$89.1K 0.1% 199
2014
Q3 		$2.91M Sell
17,537
-29
-0.2% -$4.76K 0.1% 213
2014
Q2 		$2.75M Sell
17,566
-100
-0.6% -$15.8K 0.09% 223
2014
Q1 		$2.69M Buy
17,666
+200
+1% +$31.8K 0.1% 209
2013
Q4 		$2.32M Hold
17,466
– – 0.09% 240
2013
Q3 		$2.03M Buy
17,466
+412
+2% +$45.2K 0.08% 247
2013
Q2 		$1.57M Buy
+17,054
New +$1.64M 0.06% 273

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return